News for 'FDA'

Covid vaccine boosters not appropriate at this stage: Lancet study

Covid vaccine boosters not appropriate at this stage: Lancet study

Rediff.com13 Sep 2021

The results reported from the observational studies, on average, show that vaccination had 95 per cent efficacy against severe disease both from the Delta variant and from the Alpha variant, and over 80 per cent efficacy at protecting against any infection from these variants.

3 Indian firms get FDA nod for sleep disorder drug

3 Indian firms get FDA nod for sleep disorder drug

Rediff.com26 Apr 2007

Ranbaxy Laboratories, Dr Reddy's Laboratories and Sun Pharma's US subsidiary Caraco Pharmaceuticals are among the 13 generic manufacturers to get first generic approvals from the US Food and Drug Administration to manufacture and market generic versi

Wockhardt: Recovery not in sight yet

Wockhardt: Recovery not in sight yet

Rediff.com5 Nov 2014

The news that exports to the US will not restart before next year as well as the September quarter performance are sentiment dampeners.

BJP leaders want re-election in Maharashtra

BJP leaders want re-election in Maharashtra

Rediff.com4 Nov 2019

'Many of them are angry as we could not contest in some seats due to pact with the Sena and lost with a thin margin in some segments'

Travel firms expect heavy rush as US lifts curbs

Travel firms expect heavy rush as US lifts curbs

Rediff.com18 Oct 2021

Travel companies are expecting a heavy rush to the US following the withdrawal of curbs on fully vaccinated travellers from select countries, including India, on November 8. The move will benefit those holding long-term tourist, business, and work visas. Also, new and extra flights by Air India and American Airlines are expected to provide better travel options.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Ranbaxy gets US nod to sell Alzheimer's generic

Ranbaxy gets US nod to sell Alzheimer's generic

Rediff.com22 Sep 2010

India's largest drugmaker, Ranbaxy, will have an exclusive six-month marketing opportunity to sell a generic version of Japanese drugmaker Eisai's drug for Alzheimer's in the US.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

PIX: Shocking images on cigarette packs

PIX: Shocking images on cigarette packs

Rediff.com11 Nov 2010

Should Indian cigarette packs also have photos like these to dissuade smokers? Tell us now!

Carcinogens in Johnson baby products?

Carcinogens in Johnson baby products?

Rediff.com16 Mar 2005

The Maharashtra Food and Drug Authority has issued notice to Johnson and Johnson, as six products including baby shampoo and baby oil were found to have carcinogenic substances.

'We put pressure on Biden admn over vaccines'

'We put pressure on Biden admn over vaccines'

Rediff.com13 May 2021

'Supplies should start moving to the Serum Institute without any impediments.'

Safety concerns over Maggi noodles back to haunt Nestle

Safety concerns over Maggi noodles back to haunt Nestle

Rediff.com30 Nov 2017

This time food regulators found excess presence of ash content in Maggi

FDA import ban: R'bxy hires ex-NY Mayor as advisor

FDA import ban: R'bxy hires ex-NY Mayor as advisor

Rediff.com18 Sep 2008

The US Food and Drug Administration has issued two warning letters to Ranbaxy claiming procedural violations at its plants in Dewas and Paonta Sahib in India. Giuliani, a high-profile Republican leader and former US attorney in Manhattan, would provide advice and review compliance issues. Ranbaxy has been accused of selling generic drugs which did not meet FDA standards.

Gutkha worth over Rs 7 lakh seized in Maharashtra

Gutkha worth over Rs 7 lakh seized in Maharashtra

Rediff.com1 Feb 2005

The Maharashtra Food and Drug Administration seized gutkha worth over Rs 7 lakh from various parts of the state over the last two days in an effort to enforce the ban on gutkha sales.

Manikchand's mineral water under lens

Manikchand's mineral water under lens

Rediff.com23 Jul 2004

The Maharashtra Food and Drug Administration has issued a show cause notice to a Pune-based diversified group for putting 'objectionable' label in its bottled mineral water and seized water bottles worth Rs 245,000 from Aurangabad.

Cipla gets nod to import Moderna vaccine for emergency use in India

Cipla gets nod to import Moderna vaccine for emergency use in India

Rediff.com29 Jun 2021

India's drug regulator Drugs Controller General of India has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, official sources said on Tuesday.

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

HC quashes ban on Maggi noodles, orders fresh tests

HC quashes ban on Maggi noodles, orders fresh tests

Rediff.com13 Aug 2015

The labs have been asked to submit their report within six weeks.

Boxing great Mike Tyson advocates for psychedelics

Boxing great Mike Tyson advocates for psychedelics

Rediff.com29 May 2021

Tyson said he wants to spread word of the benefits of psilocybin as widely as possible, which is why he has partnered with Wesana.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

This simple TIP will help you fight coronavirus

This simple TIP will help you fight coronavirus

Rediff.com4 Mar 2020

Meticulous hand washing is your best bet to get rid of the grime that clings to the hand, that might harbour nasty pathogens, including the coronavirus.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Rediff.com8 Apr 2014

The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general

Can You SAVE This Mother's Life?

Can You SAVE This Mother's Life?

Rediff.com2 Aug 2022

'As a donor, you may think you are saving one life. But you touch the lives of the entire family and community associated with the person. And it only cost you a few hours of your life.'

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Rediff.com6 May 2016

In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.

New York nurse first to get Covid vaccine in US

New York nurse first to get Covid vaccine in US

Rediff.com14 Dec 2020

The news comes as the United States approaches 300,000 deaths from COVID-19.

We will prevail: Trump hints at 2024 presidential bid

We will prevail: Trump hints at 2024 presidential bid

Rediff.com1 Mar 2021

Speaking at the Conservative Political Action Committee in Orlando, Florida on Sunday, the 74-year-old leader, who left the White House on January 20, stopped short of announcing to run for the president in 2024, although he gave enough indications that he is moving in that direction.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

Maharashtra to cancel licences of gutkha cos

Maharashtra to cancel licences of gutkha cos

Rediff.com29 Jan 2005

the Maharashtra Food and Drug Administration on Saturday issued directives to various departments to cancel the licences of gutkha manufacturers, wholesalers and retailers in the state after finding magnesium carbonate in gutkha.

Cipla to sell generic Flonase in US

Cipla to sell generic Flonase in US

Rediff.com9 Mar 2006

The US market for the drug is pegged at $1 billion. Cipla has been selling the product in the European market. It had won a similar case in the UK against GSK a couple of years ago.

Cadbury faces prosecution

Cadbury faces prosecution

Rediff.com7 Oct 2003

Gutkha sale banned in Maharashtra

Gutkha sale banned in Maharashtra

Rediff.com30 Jan 2005

The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.